Gene expression is tightly regulated by transcription factors and cofactors that function by directly or indirectly interacting with DNA of the genome. Understanding how and where these proteins bind provides essential information to uncover genetic regulatory mechanisms. We have developed a new method to study DNA-protein interaction in vivo called DNA adenine methyltransferase (Dam)IP, which is based on fusing a protein of interest to a mutant form of Dam from Escherichia coli. We showed previously that DamIP can efficiently identify in vivo binding sites of Dam-tethered human estrogen receptor (hER)␣. In current study, we present the cistrome of hER␣ determined by DamIP and high throughput sequencing (DamIP-seq). The DamIP-seq-defined hER␣ cistrome identifies many new binding regions and overlaps with those determined by chromatin immunoprecipitation (ChIP)-chip or ChIP-seq. Elements uniquely identified by DamIP-seq include a unique class of elements that show low, but persistent, hER␣ binding when reexamined by conventional ChIP. In contrast, DamIP-seq fails to detect some elements with very transient hER␣ binding. The methyl-adenine modifications introduced by Dam are stable and do not decrease over 12 d. In summary, the current study provides both an alternate view of the hER␣ cistrome to further understand the mechanism of hER␣-mediated transcription and a new tool to explore other transcriptional factors and cofactors that is very different from conventional ChIP. (Molecular Endocrinology 26: 349 -357, 2012) N uclear receptors are a large family of highly conserved transcription factors that respond to small lipophilic molecules and play essential roles in a wide range of physiological processes, including development, reproduction, metabolism, inflammation, cancer, and toxicology (1). Nuclear receptors bind to specific nucleotide sequences, or hormone response elements (HRE), constitutively or upon stimulation, resulting in the recruitment of diverse coregulators. Some of these coregulators harbor enzymatic activities, e.g. acetyltransferase, deacetylase, kinase, methyltransferase, etc., which can modify core histones and lead to conformational changes of chromatin, eventually modulating expression of target genes (2). This process is highly dynamic and tightly regulated by various intracellular and extracellular signals.
N uclear receptors are a large family of highly conserved transcription factors that respond to small lipophilic molecules and play essential roles in a wide range of physiological processes, including development, reproduction, metabolism, inflammation, cancer, and toxicology (1) . Nuclear receptors bind to specific nucleotide sequences, or hormone response elements (HRE), constitutively or upon stimulation, resulting in the recruitment of diverse coregulators. Some of these coregulators harbor enzymatic activities, e.g. acetyltransferase, deacetylase, kinase, methyltransferase, etc., which can modify core histones and lead to conformational changes of chromatin, eventually modulating expression of target genes (2) . This process is highly dynamic and tightly regulated by various intracellular and extracellular signals.
To understand the functions and mechanisms of nuclear receptor-mediated transcriptional regulation, it is critical to define their target genes by determining the location of nuclear receptor binding sites. Chromatin immunoprecipitation (ChIP) is currently the primary technology used to study protein-DNA interaction at the whole-genome level (3) . This method relies on a specific antibody to recognize the protein of interest, which is crosslinked to bound DNA sequences by formaldehyde. The development of genome-wide tiling microarrays and next generation high throughput sequencing makes it possible to generate global binding profiles of transcription factors called "cistromes," when combined with ChIP. These strategies have been able to elucidate the genome-wide regulation landscapes of increasing numbers of transcription factors (4) . The human estrogen receptor (hER)␣ cistrome was among the first to be studied, revealing some unexpected features (5-7): 1) a majority of hER␣ binding sites are not located close to transcription start sits but are found in intronic or intergenic regions; 2) binding motifs for forkhead transcription factor forkhead box protein A1 (FoxA1) are coenriched in hER␣ binding regions, indicating the coordination between hER␣ and FoxA1 in gene regulation; 3) some HRE are hundreds of kilobases away from the transcription start sites of their target genes, suggesting the involvement of long range chromatin looping in hER␣-mediated regulation. Recently, genome-wide mapping of hER␣-mediated long-range genomic interaction with a newly developed technology termed chromatin interaction analysis by pairedend tag sequencing (ChIA-PET) showed that most distal hER␣ binding regions bind to target gene promoters through longrange interactions (8) . Extensive chromatin looping mediated by hER␣ brings single or multiple distal enhancers hundreds kilobases away together to coordinately regulate target gene transcription.
We have developed a new method to study protein-DNA binding in vivo (9) . The method, named DNA adenine methyltransferase (Dam)IP, is based on a mutant form of Escherichia coli Dam. Dam was first used by van Steensel and Henikoff (10) to study protein DNA interactions in a related technology termed DamID. Instead of wild-type Dam, we generated a mutant form of Dam [lysine 9 to alanine (DamK9A)], reducing enzyme activity and eliminating the preference for the initial residue of its GATC target site (11) . Considering both strands, DamK9A targets only the AT dinucleotide. When DamK9A is tethered to a transcription factor and expressed in mammalian cells, the enzyme activity introduces a unique N 6 -adenine methylation into the genomic DNA. Because this modification is not normally present in eukaryotic DNA, sequences with N 6 -methyladenine can be enriched by immunoprecipitation with an appropriate antibody and analyzed by a variety of potential strategies. DamIP differs fundamentally from ChIP in that it is based on the accumulation of stable N 6 -methyladenine tags over time, typically 24 h, whereas the formaldehyde cross-linking that initiates the ChIP protocol is nearly instantaneous. Thus, DamIP yields a cumulative picture of binding events over time, whereas ChIP represents a "snapshot" of binding at a single time.
We have used hER␣ in an initial test of this method and have found that Dam-hER␣ fusion protein can be used to specifically identify both direct and indirect hER␣ DNA binding sites (9) . In the current study, we analyzed the output of DamIP at the genome-wide level by using high throughput sequencing. The hER␣ cistrome generated by DamIP-seq overlaps significantly with those defined by conventional ChIP assay and identifies new aspects of hER␣ binding kinetics. In particular, the sites uniquely identified by DamIPseq but not by previous ChIP-Chip or ChIP-seq studies include a unique class of elements that show low, but persistent, hER␣ binding. In contrast, DamIP-seq fails to identify some ChIPChip or ChIP-seq sites that show only very transient hER␣ binding upon hormone addition.
Results

Genome-wide DamIP
After successful application of DamIP to hER␣ as determined by real-time quantitative PCR (qPCR) (9), we set out to define the genome-wide profile of hER␣ by DamIP using high throughput sequencing technology (Fig. 1A) . MCF-7 cells were transiently transfected with plasmids expressing DamK9A or DamK9A-hER␣. Transfection conditions were chosen to avoid overexpression, and Western blotting confirmed that DamK9A-hER␣ expression was lower than that of the endogenous hER␣. Twenty-four hours later, cells were treated with 100 nM ␤-estradiol for 24 h before harvesting. This is a much longer time period for hormone treatment than usually used for ChIP, which is necessary for the accumulation of the N 6 -adenine methylation signal. Genomic DNA was subjected to DamIP as previously described (9) . Because the DNA enriched by DamIP is single stranded, unlike in conventional ChIP samples, we first developed a protocol to generate appropriate libraries for solexa sequencing. Single-stranded DNA was first converted to double-stranded DNA with Klenow fragment DNA polymerase and random primers and then subjected to end repair, A-tailing, adaptor ligation, PCR enrichment, and gel purification. Libraries were verified by using qPCR to determine the enrichment of the known hER␣ binding site near fibrous sheath interacting protein 1 (FSIP1) by real-time qPCR (Fig. 1B) . Finally, the libraries were sequenced, and all tags were mapped to human genome assembly hg18 (NCBI36) with Bowtie (12) . The first six nucleotides of each tag, which are likely introduced from random primers, were removed before mapping. All mapped tags were analyzed with Model-based Analysis of ChIP-Seq (13) to identify enriched regions.
As expected, DamK9A-hER␣ introduced much more methylation to the genome than DamK9A alone ( Fig.  2A) . Analysis of the distribution of the regions identified by DamIP-seq revealed that the majority of DamK9A-hER␣ target regions are located in intronic and intergenic regions (Fig. 2B) , a pattern very similar to those found in ChIP-chip and ChIP-seq of hER␣ (6, 7), and other nuclear receptors (14 -18) . Compared with the whole genome, DamK9A-hER␣ target regions are highly enriched in promoter regions, whereas DamK9A target regions are not (Fig. 2C ). Motif analysis of DamK9A-hER␣ target regions identified the canonical estrogen response element (ERE), the hexanucleotide HRE half-site, and the known ER␣ cofactor activator protein 1 binding site ( Fig. 2D ), indicating that DamIP found true ER binding sites. In addition to the expected consensus motif of the known ER␣ cofactor FoxA1, the binding site for hepatocyte nuclear factor 1B was also identified. We ranked the peaks by P values and analyzed the top and bottom 500 peaks. We found that the top 500 peaks contain 308 ERE and 392 HRE half-sites, whereas the 56 ERE and 202 HRE half-sites in the bottom 500 peaks represent a lower, but still significant, enrichment.
Comparison of DamIP with ChIP-chip and ChIP-seq
Although DamIP could be expected to generate a distinct profile of hER␣ binding sites due to its significantly different mechanism, previous results (9) confirm that it can identify many of the sites found by ChIP-chip and ChIP-seq (6, 7) . This was confirmed at the whole-genome level, because DamIP identified nearly 15,000 peaks, much greater than the other techniques, of which approximately 2400 peaks were also identified by either ChIP-chip or ChIP- -methyladenine in vivo, we used tet-on inducible lentiviral vectors to express DamK9A-hER␣ in MCF-7 cells. This system allows us to induce or reduce expression by addition or withdrawal of doxycycline. DamK9A-hER␣ was expressed for 24 h, and doxycycline was removed, and the levels of methylation at FSIP1 locus were assessed over time (Fig. 4A) . The methylation of adenine was not substantially different at over a 12-d time course (Fig. 4B) . Thus, we conclude that adenine methylation by Dam is a stable mark, at least over the time scale of days to 1 wk or more.
DamIP-seq identifies novel hER binding sites with different binding dynamics
Because of the stability of N 6 -methyladenine, DamIP generates an accumulative binding profile over time, which is very different from the nearly instantaneous profiles that result from formaldehyde cross-linking in the conventional ChIP assay. To determine whether these kinetic differences contribute to the different profiles observed, we examined the time course of occupancy of selected DamIP sites by conventional ChIP. MCF-7 cells were treated with ␤-estradiol, and cells were cross-linked and collected at different time points. Conventional ChIP assays were performed, and enrichment at various regions was quantified by real-time qPCR. For each of four peaks identified only by DamIP-seq, we were able to detect significant but relative low binding by conventional ChIP, indicating relatively low fractional occupancy. For these sites, however, the binding of hER␣ induced after ␤-estradiol treatment was persistent and decreased only relatively slowly, with significant binding remaining 24 h after treatment (Fig. 5,  top panels) . Conversely, hER␣ binding returned to basal levels within 4 h after treatment in the four peaks identified by the other technologies but missed by DamIP-seq (Fig. 5 , bottom panels). We conclude that DamIP preferentially identifies regions with more sustained binding, as expected from its different mechanistic basis. To find out whether the peaks identified only by DamIP are associated with estrogenresponsive target genes, we compared them a previously described set of such genes (6), which includes 1526 genes that are differen- tially expressed at 3, 6, or 12 h after estradiol treatment. We found 188 genes that show DamIP-seq-specific binding regions within 10 kb of the transcription start site (Fig. 6A ) but no binding peaks nearby in ChIP-chip or ChIP-seq. RT-qPCR analysis confirmed at least modest or transient estrogen responsiveness of 20 genes, including the 10 shown in Fig. 6B . Interestingly, seven of the 10 targets were repressed by ␤-estradiol treatment. We conclude that DamIP-seq detects a subset of apparently functional hER␣ binding regions not detected by the previous ChIP-chip and ChIP-seq studies.
Discussion
As the first identified nuclear receptor (19) , ER is one of the most well-studied transcription factors. The functional significance of ER has been established in many physiological processes, including reproduction, cancer, obesity, and metabolism (20) . Decades of intense research of ER has led to the elucidation of many common mechanisms of gene regulation shared by nuclear receptors. ER can regulate transcription of target genes by directly binding to ERE or by indirectly binding to DNA via other transcription factors, such as activator protein 1, nuclear factor B, or specificity protein 1 complexes (20) . ER can regulate target gene expression through distal enhancers by chromatin looping mechanisms, and recent results indicate that the majority of distal ER enhancers communicate with target gene promoters through this mechanism (8) . The recruitment of ER to ERE typically displays a cyclic pattern after ligand treatment, which is associated with time-dependent recruitment of various coregulators (21, 22) . Moreover, the transcriptional activities of ER can be differentially modulated by selective ER modulators in a tissue-specific manner (23) . The recent development of new technologies has allowed the generation of genomewide binding profiles of ER, providing an integrated picture of the ER-mediated regulatory network (6 -8, 24, 25) .
DamIP-seq defines a unique cistrome
The hER␣ cistrome determined by DamIP does include substantial and statistically significant overlap with those determined by conventional ChIP. As might be anticipated from their completely different mechanisms of action, each approach detects many sites that the other misses. We suggest that a primary contributor to the differences is the cumulative nature of the binding profiles generated by DamIP-seq. Thus, DamIP provides a distinct reflection of the dynamics of hER␣ recruitment, favoring relatively persistent, stably bound sites and disfavoring very transient ones. Further studies will be required to define the basis for the very different occupancy profiles at distinct hER␣ binding sites. In addition, although the K9A mutation strongly decreases specificity, it is possible that some sites could be affected by greater or lesser availability of potential Dam target sequences in their immediate proximity. In our motif analysis of hER␣ binding regions identified by DamIP-seq, we did see enrichment of GATC sequences, which is the target sequence of wild-type Dam, suggesting the availability of potential methylation target sequences may affect DamIP. Although we demonstrated that the DamK9A-hER␣ fusion is functional (9) , it is also possible that the attachment of Dam, a 27-kDa protein, could interfere with DNA binding properties of hER␣ via spatial or other constraints.
Nevertheless, DamIP-seq-defined cistrome does show significant overlap with ChIP-chip and ChIP-seq, confirming that DamIP is an effective way to study cistromes in vivo. In general, DamIP shows comparable or better enrichment compared with conventional ChIP. When using lentiviral transfection to express Dam-ER proteins in MCF-7 cells, we observed more than 100-fold enrichment at the FSIP1 ERE by DamIP and qPCR compared with about 17-fold by conventional ChIP assay (26) .
The larger number of hER␣ peaks identified includes apparently functional binding sites that were missed by ChIP-chip and ChIP-seq. Thus, when comparing known estrogen-responsive genes (6) with DamIP-seq-identified hER␣ binding regions, we found many potential target genes that did not have comparable peaks in the previous ChIP-chip and ChIP-seq studies. As shown in Fig. 6 , we confirmed that expression of some of these genes is responsive to estrogen treatment. Importantly, some of these genes have been shown to be estrogen responsive in independent previous research, including protein tyrosine phosphatase type IVA member 3 (27) , defender against cell death 1 (28, 29), meotic nuclear divisions 1 homolog (30), etc. We conclude that DamIP-seq is more sensitive than conventional ChIP for at least a subset of more persistent hER␣ binding regions. Such sites provide an even greater contrast with the apparently very rapid movement of ER at the time scale of seconds to minutes (31) . However, we did not observe differences in the expression of (3, 6, 24 , and 48 h) after estradiol treatment were analyzed by quantitative RT-PCR. IGFBP2, Insulin-like growth factor binding protein 2; UBB, ubiquitin B; CLDN7, claudin 7; PPT1, palmitoyl-protein thioesterase 1; MAPK3, mitogen-activated protein kinase 3; S100P, S100 calcium binding protein P; PLP2, proteolipid protein 2.
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estrogen-regulated genes near the sustained compared those with nonsustained ER␣ binding regions. Whether there are functional or mechanistic differences between the apparently more transient and more stable hER␣ binding sites is an interesting question for future study.
DamIP-seq as a novel tool to study transcription factors
We have successfully extended DamIP to the nuclear receptor liver receptor homolog 1 and assume that it can be applied to other transcription factors. As with other tagging strategies, it will be essential to confirm the appropriate function for the DamK9A fusion protein.
The interaction of transcription factors with their cis-regulatory elements is highly dynamic (21, 22) . In this context, the apparently high stability of the N 6 -methyladenine modification can provide a unique view of occupancy over time that extends beyond the preference for more or less stable sites. Thus, we have shown that DamIP can easily detect the previous occupancy of hER␣ on a specific site at a time point more than 1 wk after hER␣ expression was shut off. It is likely that DamIP could be used to identify transient binding of an appropriately engineered transcription factor to a specific site days or possibly weeks or more after the binding event, particularly in nonreplicating cells. Because there is no mechanism to copy them, the N 6 -methyladenine tags should be segregated in a hemizygous state to the daughters of the originally marked cell. In proliferating cell populations, the tags would then be sequentially dispersed in subsequent cell divisions. In this context, DamIP could be viewed as a very different mechanism for lineage tracing capable of identifying the cellular products of a specific genetic regulatory event.
In summary, we have determined the hER␣ cistrome defined by our DamIP-seq. This new technology is completely different from conventional ChIP and generates a unique cumulative binding profiles of transcription factors. DamIP provides a unique alternative to ChIP that will facilitate the identification of target genes and dissection of the mechanisms of transcriptional regulation.
Materials and Methods
Plasmids
For transient expression of DamK9A, Dam sequence with mutation that changes lysine 9 to alanine (AAG to GCG) was cloned into a pCMX vector with a 3xFLAG tag at N terminus. The sequence of hER␣ was inserted after 3xFLAG tag to generate pCMX-DamK9A-hER␣ for transient expression. For inducible lentiviral vectors, DamK9A or DamK9A-hER␣ sequences were cloned into pLVX Tet-on Advanced vector (Clontech, Mountain View, CA), and lentivirus was produced according to manufacture's instructions.
Cell culture
Human breast cancer cell line MCF-7 was maintained in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) and 1ϫ nonessential amino acids (NEAA) (Invitrogen). For experiments with ligand treatment, MCF-7 cells were plated in phenol red-free DMEM supplemented with 10% charcoal-stripped FBS and 1ϫ NEAA for at least 3 d before treatment. For inducible expression of DamK9A or DamK9A-hER␣, cells were maintained in DMEM supplemented with Tet system approved FBS (Clontech) and 1ϫ NEAA for at least 5 d before lentiviral transduction.
DNA adenine methyltransferase IP
DamIP was performed as previously described (9) . Briefly, genomic DNA was harvested from cells by ribonuclease A and proteinase K treatment and purified by phenol-chloroform extraction. Ten micrograms of genomic DNA were denatured by boiling in water for 10 min and incubated with 5-g pretreated anti-N 6 -methyladenine antibody (MegaBase Research, Lincoln, NE) for 2 h at room temperature followed by incubation with A/G plus agarose (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Enriched DNA was treated with proteinase K and purified with QIAQuick PCR purification kit (QIAGEN, Valencia, CA).
Solexa sequencing and data analysis
After verification with real-time qPCR, DamIP-enriched DNA was first converted to double strand DNA. About 30 ng of DNA were incubated in a 40-l reaction with 1.5 g of random hexamers and 25 U Klenow exo Ϫ fragment (New England Biolabs, Ipswich, MA) at 25 C for 30 min. The reaction was purified with QIAQuick PCR purification kit (QIAGEN) and subjected to solexa library construction with Genomic DNA Sample Prep kits (Illumina, San Diego, CA) according to manufacture's instructions. The libraries were sequenced on a Genome Analyzer IIe.
DamIP-seq data analysis
Short sequence tags generated from Illumina pipeline were mapped to human genome hg18 (NCBI36) with Bowtie (12) . First six nucleotides were removed before Bowtie mapping. Bowtie aligned sequences tags were subjected to peak calling by Model-based Analysis of ChIP-Seq (13) . A P value of 10 Ϫ5 was used as the cut-off for peak calling. De novo motif discovery was performed with MEME (32) and MDScan (33) . Motif analysis and ChIP regions analysis were done with the SeqPos and CEAS modules, respectively, through the cistrome pipeline (34). Comparison of different binding regions were performed with BEDTools (35) . The raw data are available at http://www.ncbi.nlm. nih.gov/geo/query/acc. cgi?accGSE33804 (GEO accession number GSE33804).
Chromatin immunoprecipitation
Time-course ChIP was performed as described (21) with some modifications. Briefly, MCF-7 cells were cultured in phenol red-free DMEM supplemented with 10% charcoal-stripped FBS and were collected at different time points after 100 nM ␤-estradiol treatment. After removing culture media, cells were cross-linked by incubating with 1ϫ PBS containing 1% formal-dehyde for 10 min at room temperature. Cells then were harvested and sonicated. Soluble chromatin was precleared with preimmune serum and protein A Dynabeads (Invitrogen) for 2 h at 4 C followed with immunoprecipitation with anti-ER␣ antibodies (HC-20; Santa Cruz Biotechnology, Inc.) for 6 h or overnight at 4 C. After immunoprecipitation, 30 l of pretreated protein A-Dynabeads and 2 g of salmon sperm DNA were added, and the incubation was continued for another 1 h. Precipitates were washed sequentially for 10 min each in buffer I [0.1% sodium dodecyl sulfate (SDS), 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), and 150 mM NaCl], buffer II [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM TrisHCl (pH 8.1), and 500 mM NaCl], and buffer III [0.25 M LiCl, 1% Nonidet P-40, 1% deoxycholate, 1 mM EDTA, and 10 mM Tris-HCl (pH 8.1)]. Precipitates were then washed three times with Tris-EDTA buffer and extracted twice with 1% SDS and 0.1 M NaHCO 3 . Eluates were pooled and heated at 65 C for at least 6 h to reverse the formaldehyde cross-linking. DNA fragments were purified with a QIAQuick PCR Purification kit (QIAGEN). . Twenty-four hours after infection, cells were selected with 500 g/ml G418 and 1 g/ml puromycin for 4 d. Then cells were trypsinized and plated into six-well plates. Twenty-four hours later, cells were treated with 1 g/ml doxycycline and 100 nM ␤-estradiol for 24 h and were replaced with fresh media without doxycycline and estradiol. Cells were collected before doxycycline and estradiol treatment or 1, 4, 7, and 12 d after treatment for Western blotting and DamIP.
